Thabane, Alex http://orcid.org/0000-0002-1516-9584
Phillips, Mark R. http://orcid.org/0000-0003-0923-261X
Wong, Tien Y.
Thabane, Lehana http://orcid.org/0000-0003-0355-9734
Bhandari, Mohit http://orcid.org/0000-0001-9608-4808
Chaudhary, Varun http://orcid.org/0000-0002-9988-4146
Wykoff, Charles C.
Sivaprasad, Sobha
Kaiser, Peter
Sarraf, David
Bakri, Sophie
Garg, Sunir J.
Singh, Rishi P.
Holz, Frank G.
Guymer, Robyn H.
,
Article History
Received: 11 November 2021
Revised: 12 November 2021
Accepted: 16 November 2021
First Online: 21 January 2022
Competing interests
: T.Y.W. is the Advisory Board Member and receive financial support from Allergan, Bayer, Boehringer-Ingelheim, Genentech, Merck, Novartis, Oxurion (formerly ThromboGenics), Roche, Samsung Bioepis, Novartis Singapore; Co-founder of Plano, EyRiS. M.B. receive research funds from Pendopharm, Bioventus, Acumed – unrelated to this study. V.C. is the Advisory Board Member of Alcon, Roche, Bayer, Novartis; receive grants from Bayer, Novartis – unrelated to this study. A.T., M.R.P. and L.T. declare no competing interests.
Free to read: This content has been made available to all.